Alcohol and acetaminophen hepatotoxicity [5]

Archives of Internal Medicine

Volumn 163, Issue 2, 2003, Pages 244-245

  Dart, Richard C ^a   Kuffner, Edwin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; CYTOCHROME P450 2E1; PARACETAMOL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ANALGESIA; ENZYME ACTIVITY; HIGH RISK PATIENT; HUMAN; INCIDENCE; LETTER; LIVER TOXICITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037467755     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.2.244-c     Document Type: Letter

References (7)

1. Kuffner EK, Dart RC, Bogdan GM, et al. Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med. 2001;161:2247-2252.
2. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337-344.
3. Soll AH, Sees KL. Is acetaminophen really safe in alcoholic patients [letter]? Arch Intern Med. 2002;162:1194.
4. Oviedo J, Wolfe MM. Alcohol, acetaminophen, and toxic effects on the liver [letter]. Arch Intern Med. 2002;162:1194-1195.
5. Kuffner EK, Bogdan GM, Dart RC. Evaluation of hepatotoxicity in alcoholics from therapeutic dosing of acetaminophen [abstract.] Toxicol Clin Toxicol. 1997;35:561.
6. Holtzman JL. The effect of alcohol on acetaminophen hepatotoxicity [letter]. Arch Intern Med. 2002;162:1193.
7. Lucas D, Menez C, Girre C, Bodenez P, Hispard E, Menez JF. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res. 1995;193:362-366.